Harvard Bioscience Stock
-
Your prediction
Harvard Bioscience Stock
Pros and Cons of Harvard Bioscience in the next few years
Pros
Cons
Performance of Harvard Bioscience vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Harvard Bioscience | - | - | - | - | - | - | - |
| MicroVision Inc | 0.830% | -16.321% | -48.748% | -72.556% | -64.392% | -92.593% | -98.276% |
| Simulations Plus | -0.640% | 0.641% | 9.028% | -57.568% | 1.948% | -57.568% | -65.870% |
| Fluidigm Corp. | -4.620% | -5.926% | -34.872% | -35.859% | -40.094% | -63.295% | -87.919% |
Comments
News
The Hidden Forces Behind Every Investment Decision
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributor Rachel Warren talks with Harvard-trained behavioral scientist Julia Dhar, author of How Change Really Works, about why
Harvard University Sold Some Bitcoin and Ethereum in Q1. Should You?
When one of the world's wealthiest universities makes an apparently sudden and unexpected reshuffle of its crypto holdings, it tends to make a splash. On that note, Harvard's endowment fully
Federal Reserve Chairman Jerome Powell Just Delivered Fantastic News for Stock Market Investors
Ongoing geopolitical tensions in the Middle East have triggered a surge in oil prices, stoking fears of an inflation spike that could derail the U.S. economy. The last time inflation suddenly


